vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and StepStone Group Inc. (STEP). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $586.5M, roughly 1.7× StepStone Group Inc.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs -21.0%, a 26.5% gap on every dollar of revenue. On growth, StepStone Group Inc. posted the faster year-over-year revenue change (73.0% vs 33.2%). StepStone Group Inc. produced more free cash flow last quarter ($26.7M vs $23.5M). Over the past eight quarters, StepStone Group Inc.'s revenue compounded faster (28.2% CAGR vs 27.1%).

Rosetta Stone Inc. is an American education technology software company that develops language, literacy and brain-fitness software. Best known for its language-learning products, in 2013, the company expanded beyond language into education-technology with its acquisitions of Livemocha, Lexia Learning, Fit Brains, and Tell Me More. In 2021, it became a subsidiary of IXL Learning.

ECG vs STEP — Head-to-Head

Bigger by revenue
ECG
ECG
1.7× larger
ECG
$1.0B
$586.5M
STEP
Growing faster (revenue YoY)
STEP
STEP
+39.8% gap
STEP
73.0%
33.2%
ECG
Higher net margin
ECG
ECG
26.5% more per $
ECG
5.5%
-21.0%
STEP
More free cash flow
STEP
STEP
$3.2M more FCF
STEP
$26.7M
$23.5M
ECG
Faster 2-yr revenue CAGR
STEP
STEP
Annualised
STEP
28.2%
27.1%
ECG

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
ECG
ECG
STEP
STEP
Revenue
$1.0B
$586.5M
Net Profit
$55.3M
$-123.5M
Gross Margin
11.6%
Operating Margin
6.8%
-33.2%
Net Margin
5.5%
-21.0%
Revenue YoY
33.2%
73.0%
Net Profit YoY
60.4%
35.7%
EPS (diluted)
$1.09
$-1.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
STEP
STEP
Q4 25
$1.0B
$586.5M
Q3 25
$986.8M
$454.2M
Q2 25
$921.5M
$364.3M
Q1 25
$826.6M
$377.7M
Q4 24
$759.6M
$339.0M
Q3 24
$761.0M
$271.7M
Q2 24
$703.4M
$186.4M
Q1 24
$625.7M
$356.8M
Net Profit
ECG
ECG
STEP
STEP
Q4 25
$55.3M
$-123.5M
Q3 25
$57.0M
$-366.1M
Q2 25
$52.8M
$-38.4M
Q1 25
$36.7M
$-18.5M
Q4 24
$34.5M
$-192.0M
Q3 24
$41.8M
$17.6M
Q2 24
$39.0M
$13.3M
Q1 24
$28.2M
$30.8M
Gross Margin
ECG
ECG
STEP
STEP
Q4 25
11.6%
Q3 25
12.6%
Q2 25
13.0%
Q1 25
11.2%
Q4 24
11.4%
Q3 24
11.8%
Q2 24
12.6%
Q1 24
11.9%
Operating Margin
ECG
ECG
STEP
STEP
Q4 25
6.8%
-33.2%
Q3 25
7.3%
-148.8%
Q2 25
7.9%
-5.6%
Q1 25
6.2%
2.6%
Q4 24
6.1%
-101.7%
Q3 24
7.1%
21.3%
Q2 24
7.3%
29.4%
Q1 24
6.2%
26.5%
Net Margin
ECG
ECG
STEP
STEP
Q4 25
5.5%
-21.0%
Q3 25
5.8%
-80.6%
Q2 25
5.7%
-10.5%
Q1 25
4.4%
-4.9%
Q4 24
4.5%
-56.6%
Q3 24
5.5%
6.5%
Q2 24
5.5%
7.2%
Q1 24
4.5%
8.6%
EPS (diluted)
ECG
ECG
STEP
STEP
Q4 25
$1.09
$-1.55
Q3 25
$1.11
$-4.66
Q2 25
$1.03
$-0.49
Q1 25
$0.72
$-0.37
Q4 24
$0.68
$-2.61
Q3 24
$0.82
$0.26
Q2 24
$0.76
$0.20
Q1 24
$0.55
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
STEP
STEP
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$281.5M
$270.2M
Stockholders' EquityBook value
$629.8M
$-378.8M
Total Assets
$1.7B
$5.2B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
STEP
STEP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$553.0K
Q2 24
Q1 24
Total Debt
ECG
ECG
STEP
STEP
Q4 25
$281.5M
$270.2M
Q3 25
$285.1M
$269.9M
Q2 25
$288.6M
$269.6M
Q1 25
$292.1M
$269.3M
Q4 24
$295.6M
$168.9M
Q3 24
$172.3M
Q2 24
$172.1M
Q1 24
$148.8M
Stockholders' Equity
ECG
ECG
STEP
STEP
Q4 25
$629.8M
$-378.8M
Q3 25
$573.0M
$-233.5M
Q2 25
$514.4M
$153.9M
Q1 25
$460.2M
$179.4M
Q4 24
$422.6M
$209.8M
Q3 24
$453.3M
$397.5M
Q2 24
$490.0M
$366.9M
Q1 24
$464.3M
$324.5M
Total Assets
ECG
ECG
STEP
STEP
Q4 25
$1.7B
$5.2B
Q3 25
$1.6B
$5.3B
Q2 25
$1.5B
$4.8B
Q1 25
$1.4B
$4.6B
Q4 24
$1.3B
$4.3B
Q3 24
$1.3B
$4.0B
Q2 24
$3.8B
Q1 24
$3.8B
Debt / Equity
ECG
ECG
STEP
STEP
Q4 25
0.45×
Q3 25
0.50×
Q2 25
0.56×
1.75×
Q1 25
0.63×
1.50×
Q4 24
0.70×
0.81×
Q3 24
0.43×
Q2 24
0.47×
Q1 24
0.46×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
STEP
STEP
Operating Cash FlowLast quarter
$48.2M
$27.2M
Free Cash FlowOCF − Capex
$23.5M
$26.7M
FCF MarginFCF / Revenue
2.3%
4.6%
Capex IntensityCapex / Revenue
2.4%
0.1%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M
$18.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
STEP
STEP
Q4 25
$48.2M
$27.2M
Q3 25
$76.2M
$16.2M
Q2 25
$25.3M
$46.3M
Q1 25
$7.1M
$-66.5M
Q4 24
$27.6M
Q3 24
$78.9M
$53.7M
Q2 24
$50.2M
Q1 24
$21.9M
$7.6M
Free Cash Flow
ECG
ECG
STEP
STEP
Q4 25
$23.5M
$26.7M
Q3 25
$65.7M
$15.9M
Q2 25
$12.3M
$45.2M
Q1 25
$-11.4M
$-69.2M
Q4 24
$27.0M
Q3 24
$60.9M
$52.4M
Q2 24
$49.6M
Q1 24
$12.6M
$6.7M
FCF Margin
ECG
ECG
STEP
STEP
Q4 25
2.3%
4.6%
Q3 25
6.7%
3.5%
Q2 25
1.3%
12.4%
Q1 25
-1.4%
-18.3%
Q4 24
8.0%
Q3 24
8.0%
19.3%
Q2 24
26.6%
Q1 24
2.0%
1.9%
Capex Intensity
ECG
ECG
STEP
STEP
Q4 25
2.4%
0.1%
Q3 25
1.1%
0.1%
Q2 25
1.4%
0.3%
Q1 25
2.2%
0.7%
Q4 24
0.2%
Q3 24
2.4%
0.5%
Q2 24
0.3%
Q1 24
1.5%
0.3%
Cash Conversion
ECG
ECG
STEP
STEP
Q4 25
0.87×
Q3 25
1.34×
Q2 25
0.48×
Q1 25
0.19×
Q4 24
Q3 24
1.89×
3.05×
Q2 24
3.76×
Q1 24
0.77×
0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

STEP
STEP

Other$210.1M36%
Management And Advisory Fees Net Focused Commingled Funds$143.3M24%
Carried Interest Allocation Focused Commingled Funds$85.1M15%
Carried Interest Allocation Separately Managed Accounts$63.6M11%
Carried Interest Allocation Realized$46.7M8%
Management And Advisory Fees Net Advisory And Other Services$18.3M3%
Legacy Carried Interest Allocation Focused Commingled Funds$10.3M2%
Income Based Incentive Fees$6.0M1%
Management And Advisory Fees Net Fund Reimbursement Revenues$3.1M1%

Related Comparisons